Skip to main content
Premium Trial:

Request an Annual Quote

Gap in COVAX Doses

COVAX has received none of its expected vaccine shipments from the Serum Institute of India since March, leading to shortfall in doses, BBC News reports.

The COVAX Global Vaccines Facility was established to ensure global sharing and equitable distribution of SARS-CoV-2 vaccines and has a goal of delivering 2 billion vaccine doses by the end of the year. The effort, though, ran into difficulties as wealthier nations secured vaccine access directly from manufacturers, rather than through COVAX. Still, in February, the program announced its first shipment of vaccines to Ghana.

However, as Business Insider notes, the largest supplier of vaccines to the program is SII, but it halted exports in March to focus on domestic demand. "Unfortunately, we're in a situation where we just don't know when the next set of doses will materialize," Gian Gandhi, UNICEF's COVAX coordinator for supply, tells the BBC.

UNICEF, which is leading procurement for the effort, estimates that the shortfall will reach 190 million doses by next month, and it urges G7 leaders to share their excess vaccine supply. The BBC adds that COVAX has recently signed agreements with other manufacturers to bolster its supply, but that those won't yet fill the gap.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.